It costs pennies a day but has had one of the greatest impacts on the reduction of death from heart attack than any other intervention. Among the top causes of death in the US are strokes and heart attacks and aspirin has had a significant role in the prevention of aplenty of deaths.
And yet, it comes with numerous risks.
However, a recent study has revealed some spectacular results associated with ovarian cancer. A remarkable 20-34% reduced risk of ovarian cancer has been found, depending on the dose and frequency of use. The highest reduction of ovarian cancer rate was seen in more regular users of low dose aspirin (<100mg/day).
This is great news in many aspects.
Ovarian cancer cure continues to evade us as no detection strategies have been exposed to help with diagnosis and treatment at an early stage. Which is why it is usually detected at a more advanced stage when the chances for cure are less.
So the question is, how can aspirin help beat off the onset of Ovarian cancer? Endometriosis – among the established risk factors associated to inflammatory processes can be reduced using aspirin. Along with the risk of developing the disease.
Does this tell us that women ought to start taking aspirin? This is a tricky question as weighing adverse and desired effects is imperative, along with the known complications of the use of aspirin. Upper gastrointestinal bleeding, hemorrhagic stroke and peptic ulcer pose solemn health threats. With this in mind, current science supports aspirin use among high-risk groups, but not for everyone.
We can conclude that for women, a low daily dose of aspirin (81 or 100 mg/day) may decrease your risk of ovarian cancer. If you are young and healthy but have risk factors (personal history of breast cancer, family history of ovarian cancer, obesity, endometriosis or fertility treatments of long durations) ask for your doctors’ advice about daily aspirin. We think its worth it.
